Vinati Organics (524200) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
7 Sep, 2026Executive summary
Unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2024, were approved and published.
Board approved the establishment of a wholly owned subsidiary in the United States to expand offshore operations and explore new opportunities.
Board revised several key governance policies, including materiality, related party transactions, and insider procedures.
Financial highlights
Consolidated revenue from operations for Q3 FY25 was ₹521.68 crore, up from ₹447.99 crore in Q3 FY24; nine-month revenue was ₹1,599.71 crore, up from ₹1,349.64 crore year-over-year.
Net profit for Q3 FY25 stood at ₹93.70 crore, compared to ₹76.94 crore in Q3 FY24; nine-month net profit was ₹282.21 crore, up from ₹218.82 crore year-over-year.
Standalone revenue for Q3 FY25 was ₹521.67 crore, up from ₹447.99 crore in Q3 FY24; nine-month standalone revenue was ₹1,599.65 crore, up from ₹1,349.64 crore year-over-year.
Standalone net profit for Q3 FY25 was ₹95.55 crore, compared to ₹77.02 crore in Q3 FY24; nine-month standalone net profit was ₹287.66 crore, up from ₹218.90 crore year-over-year.
Basic and diluted EPS for Q3 FY25 were ₹9.04 (consolidated) and ₹9.22 (standalone), compared to ₹7.42 and ₹7.43 in Q3 FY24, respectively.
Outlook and guidance
The new US subsidiary is expected to drive growth by manufacturing and selling products in the US and exploring further market opportunities.
Latest events from Vinati Organics
- Strong revenue and profit growth reported for Q1 FY25, with robust performance in chemicals manufacturing.524200
Q1 24/25 - Strong year-over-year growth in revenue and profit, with robust cash flow and equity position.524200
Q2 24/25 - FY25 saw robust profit growth, a Rs.7.50 dividend, and expansion with a new US subsidiary.524200
Q4 24/25 - Q1 margin rose to 30% on lower costs; year-over-year profit and revenue growth with strong outlook.524200
Q1 25/26 - Margins expanded and profits rose, supported by capacity growth and a CFO transition.524200
Q2 25/26 - Q3 FY26 delivered higher revenues and profits year-over-year, with robust financial health.524200
Q3 25/26 - Strong Q4 growth, robust audited results, and double-digit volume growth targeted for FY 2027.524200
Q4 25/26 - Revenue and profit rose with stable margins; capacity expansion to support future growth.524200
Q1 26/27